Clinical Trial Update: To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction. [Phase 2]

View source ↗

Summary

A Phase 2 trial completed to determine the minimum dose of Artemisia vulgaris allergen extract that produces a positive skin reaction in individuals with pollen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Pollen Allergy

Drugs mentioned

• Artemisia vulgaris allergen extract (Artemisia vulgaris allergen extract)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Allergy to Pollen | Phase 2 | Status: COMPLETED